Next Article in Journal
Synthesis and Properties of Poly[p-(2,5-dihydroxy)- phenylenebenzobisoxazole] Fiber
Next Article in Special Issue
Survey of Slaughtered Pigs for Occurrence of Ochratoxin A and Porcine Nephropathy in Serbia
Previous Article in Journal / Special Issue
Effects of Milling and Cooking Processes on the Deoxynivalenol Content in Wheat
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

T-2 Toxin-induced Toxicity in Pregnant Mice and Rats

1
Nippon Institute for Biological Science, 9-2221-1, Shin-Machi, Ome, Tokyo 198-0024, Japan
2
Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo, Tokyo 113-8657, Japan
3
Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., 5-10 Yamagishi, Mikuni-Cho, Sakai-Shi, Fukui 913-0032, Japan
4
Daiichi Sankyo Inc., 399 Thornall Street, Edison, NJ 08837, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2008, 9(11), 2146-2158; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms9112146
Submission received: 17 October 2008 / Revised: 31 October 2008 / Accepted: 4 November 2008 / Published: 5 November 2008

Abstract

:
T-2 toxin is a cytotoxic secondary fungal metabolite that belongs to the trichothecene mycotoxin family. This mycotoxin is a well known inhibitor of protein synthesis through its high binding affinity to peptidyl transferase, which is an integral part of the ribosomal 60s subunit, and it also inhibits the synthesis of DNA and RNA, probably secondary to the inhibition of protein synthesis. In addition, T-2 toxin is said to induce apoptosis in many types of cells bearing high proliferating activity. T-2 toxin readily passes the placenta and is distributed to embryo/fetal tissues, which include many component cells bearing high proliferating activity. This paper reviews the reported data related to T-2 toxin-induced maternal and fetal toxicities in pregnant mice and rats. The mechanisms of T-2 toxin-induced apoptosis in maternal and fetal tissues are also discussed in this paper.

Graphical Abstract

1. Introduction

T-2 toxin is a cytotoxic secondary fungal metabolite that belongs to the trichothecene mycotoxin family. They are produced by various species of Fusarium (F. sporotichioides, F. poae, F. equiseti, F. acuminatum), which can infect corn, wheat, barley and rice crops in the field or during storage [1, 2]. T-2 toxin is conjectured to be a major factor in alimentary toxic aleukia in humans [3] and has been implicated in additional mycotoxicoses such as red mold disease in humans and animals [4] and bean-hull poisoning in horses [5].
T-2 toxin is a well-known inhibitor of protein synthesis through its high binding affinity to peptidyltransferase which is an integral part of the 60s ribosomal subunit [68]. Subsequent inhibition of the peptidyl transferase reaction can trigger a ribotoxic stress response that activates c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinases (MAPKs) [6]. T-2 toxin also inhibits the synthesis of DNA and RNA, probably secondary to inhibition of protein synthesis [8, 9]. Moreover, T-2 toxin interferes with the metabolism of membrane phospholipids and increases liver lipid peroxides [10, 11].
The toxic effects of T-2 toxin have been studied in experimental animals – poultry, cattle, sheep and pigs – all of which appear to be sensitive to this mycotoxin. Among farm animals, pigs are the most sensitive species [8], and ruminants are more resistant to the adverse effects of T-2 toxin due to microbial degradation within rumen microorganisms [12].
Oral, parenteral and cutaneous exposures to T-2 toxin induce lesions in hematopoietic, lymphoid and gastrointestinal tissues and suppress reproductive organ functions [1316]. In addition, cardiomyopathy has been reported after topical application of T-2 toxin to rats [17], and signs somewhat similar to those in human alimentary toxic aleukia have been reported in rhesus monkeys and cats fed T-2 toxin [18]. The exact mechanism of T-2 toxin-induced lesions has remained unclear for many years. However, Quiroga et al. [19] have found that the thymocytes of T-2 toxin-inoculated mice undergo ultrastructural changes suggestive of apoptotic cell death. Thereafter, our research group showed in a series of experiments using adult mice and rats that T-2 toxin induces apoptotic cell death of lymphocytes in the thymus, splenic white pulp [20], and Peyer’s patches [21], hematopoietic cells in the bone marrow and splenic red pulp [22], intestinal crypt epithelial cells [23], and epidermal basal cells [24], suggesting that T-2 toxin can induce apoptosis in many types of cells bearing high proliferating activity. In addition, Shinozuka et al. [25] reported that T-2 toxin also induces apoptosis and fatty change in hepatocytes of mice following the increased expression of both oxidative stress-related, and apoptosis-related genes ( c-fos and c-jun). The elevated expression of oncogenes (c-jun and c-fos) as well as cytokines (TNF-alpha, TGF-beta1 and IL-1beta) is also reported in keratinocytes of rats topically applied with T-2 toxin [2629].
T-2 toxin readily passes through the placenta and is distributed to embryo/fetal tissues which include many component cells bearing high proliferating activity [30]. This paper reviews the T-2 toxin-induced toxicity in pregnant mice and rats, although there are not so many reports of T-2 toxin-exposure to pregnant animals.

2. Maternal toxicity

Most of the reports of T-2 toxin-exposure to pregnant mice and rats are focused on embryo/fetal toxicity, with little reference to maternal toxicity [13, 3040]. Sehata et al. [41, 42] examined the maternal toxicity in detail in pregnant rats exposed to a single oral dose of T-2 toxin (2 mg/kg) on day 13 of gestation. In their experiments, apoptosis was induced in lymphoid, hematopoietic and gastrointestinal tissues and liver as described in the above-mentioned reports in adult mice. It is said that the c-fos gene plays an important role in the early phase of T-2 toxin-induced apoptosis in the lymphoid and hematopoietic tissues probably through the synthesis of a certain apoptosis-related protein [43]. The elevation of c-fos expression requires the mobilization of [Ca2+]i and partially involves a protein kinase C (PKC)-dependent pathway, and the mobilization of [Ca2+]i activates calcium-dependent caspases, resulting in internucleosomal DNA fragmentation [44, 45]. T-2 toxin-induced apoptosis in hematopoietic and lymphoid tissues is considered to be independent of the Fas/Fas ligand pathway [43, 46] and the p53-related pathway [43].
Hemorrhage with apoptosis of cytotrophoblasts was observed in the placenta of a small percent of pregnant rats exposed to a single oral dose of T-2 toxin (2mg/kg) [41]. Placental hemorrhage is also reported in a small percent of pregnant mice exposed to a single oral dose of T-2 toxin (3 mg/kg) on either day 7, 8, 10, 11 or 12 of gestation [33, 36, 47]. The cause of such placental hemorrhage may be a result of the direct cytotoxic effect of T-2 toxin on the delicate vasculature in the labyrinth zone [41, 48], an effect of T-2 toxin on the clotting system, either by depressing clotting factors [49], or disturbing platelet function [50], or a combination of both [47]. In this regard, the prolongation of both prothrombin time and activated partial thromboplastin time and the decrease in the expression of blood coagulation-related genes (factors V, VII and X, kallikrein, and vitamin K epoxide reductase complex, subunit 1) are reported in adult mice exposed to a single oral dose of T-2 toxin (10 mg/kg) [25].
Rousseaux et al. [51] reported that no long-term reproductive and teratological effects of low dose dietary T-2 toxin (1.5 and 3.0 ppm) were found in the two-generation female reproduction and teratology study.

3. Fetal toxicity

As mentioned above, T-2 toxin readily passes through the placenta and is distributed to the fetal tissues [30], resulting in the induction of embryo/fetal death, fetal brain damage and fetal bone malformation [36]. In addition, thymic atrophy due to reduction in the number of CD44low and CD45low fetal liver prolymphocytic cells and prothymocytes and suppression of humoral immunity due to reduction in CD45R+B cell precursors have been reported in the mouse fetus from dams exposed to T-2 toxin from days 14–17 of gestation at dose levels (1.2 or 1.5 mg/kg) below that where other toxicities are observed [37, 38]. This indicates that the developing immune system may be a particular sensitive target of T-2 toxin exposure. Murine ontogenic development of thymocytes in the thymus originates from precursor cells in the fetal liver that seed the thynic rudiment on day 10–11 of gestation [52, 53], and the fetal thymus contains significantly greater proportions of immature proliferating thymocytes than are present in corresponding adult models [53]. The difference in susceptibility to T-2 toxin among lymphocyte subsets is also observed in adult mice [54], and the difference in the degree of lymphocyte apoptosis among lymphoid tissues reflects the difference in the lymphocyte population susceptible to T-2 toxin among lymphoid tissues [20, 54]. Conversely, Blakley et al. [35] reported that prenatal exposure to a single oral dose (0.75 or 1.5 mg/kg) of T-2 toxin on day 11 of gestation did not produce any impairment of humoral immunity and direct cytotoxic manifestations of T-2 toxin on antibody-producing cells were not observed, although the morphological and functional development of the murine immune system is said to be particularly sensitive to toxic insult during days 10–12 of gestation [55]. Blakley et al. [35] suggested that the embryolethal effects are a primary limiting factor which may preclude the expression of any immunoteratological manifestations associated with humoral immunity under natural field conditions.
It has been considered that T-2 toxin is primarily maternotoxic and embryolethal, and that defective development and induction of malformations are possibly secondary to maternal toxicity [13, 32, 36], although how the fetus is damaged by maternal toxicity is still unknown. On the other hand, Ishigami et al. [39] first reported that T-2 toxin (3 mg/kg) can induce apoptosis, especially in the central nervous and skeletal systems after oral administration to pregnant mice, indicating the direct cytotoxic effect of T-2 toxin on fetal tissues. They demonstrated that T-2 toxin-induced skeletal malformations and telencephalic lesions are greatly reduced by pretreatment with cyclohexamide, a protein synthesis inhibitor, as reported in thymocyte apoptosis in adult mice exposed to T-2 toxin (10 mg/kg) [43]. In addition, the number and region of apoptotic cells induced in the mouse fetus by T-2 toxin (3 mg/kg) vary according to the embryonic day. For example, apoptosis is observed in many neuronal progenitor cells and a small number of chondroblasts and chondrocytes on embryonic day 13.5 while it is detected in many cells in the thymus and renal subcapsular parenchyma on embryonic day 16.5 [40]. In rat fetuses from dams exposed to T-2 toxin (2 mg/kg) on day 13 of gestation, apoptosis is observed mainly in the central nervous system, liver (both hepatocytes and hematopoietic cells), gastrointestinal tract and cartilage primordium [41]. Apoptosis of hematopoietic cells in the fetal liver is considered to be similar to that in the spleen and bone marrow reported in adult mice treated with T-2 toxin (10 mg/kg) [22].
T-2 toxin is generally considered to induce apoptosis in actively proliferating cells in embryos and fetuses, probably through its radiomimetic effect. However, it should not be forgotten that a small number of apoptotic cells are also observed in some regions where proliferating cell nuclear antigen (PCNA)-positive cells are not detected [40], suggesting that T-2 toxin-induced apoptosis in the developing mouse fetus might also be affected by some other factors in addition to the proliferating activity of target cells. Similar findings are also reported in the intestinal crypt epithelial cells of adult mice exposed to T-2 toxin [23, 56].
Bone malformation such as incomplete ossification, absence of bones, wavy bones and fused bones that is one of the most frequently observed fetotoxicities of T-2 toxin [13, 32, 34, 36] is now considered to be related to T-2 toxin-induced apoptosis in the caudal half of the sclerotome around the notochord, and in the mesenchyme, chondroblasts and chondrocytes around cartilage primordium [40]. Judging from the results of in vitro studies, it is suggested that T-2 toxin (8 ng/mL) injures chondrocytes through superinduction of IL-1beta and IL-6 [57] and that apoptosis of chondrocytes can be induced by T-2 toxin (1–20 ng/mL) via the Bcl-2 and Bax proteins and the Bax/Bcl-2 ratio may play a critical role in governing the susceptibility to T-2 toxin-induced apoptosis in chondrocytes [58]. Prenatal exposure to T-2 toxin may also induce chondrocyte apoptosis in the fetus in the fetus through similar mechanisms, resulting in bone malformation.
As mentioned above, T-2 toxin passes through the placenta [30], and the blood brain barrier is not completely developed before embryonic day 18 in rats [59]. In addition, T-2 toxin and its metabolite, Ht-2, have a lipophilic nature and the fetal brain is rich in lipids. Therefore, T-2 toxin may be easily distributed to the fetal brain. Sehata et al. [60] have investigated the mechanisms of apoptosis induction in the fetal brain by the oral administration of T-2 toxin (2 mg/kg) to pregnant rats on day 13 of gestation. The number of apoptotic neuronal progenitor cells in the telencephalon increased at 1 hr and peaked at 12 hr. Based on the results of DNA microarray analysis and real time PCR done on the fetal brain at 6, 12 and 24 hr, they concluded that the T-2 toxin-induced toxicity in the fetal brain is due to oxidative stress, and that MAPK pathway (especially MEKK1 and c-jun) is involved in T-2 toxin-induced apoptosis in the fetal brain. In addition, the increase in caspase-2 gene expression with no changes in caspase-9 and Bax-alpha gene expression was also detected, suggesting an involvement of caspase-2 activation in T-2 toxin-induced apoptosis in the fetal brain. Acivation of caspase-2 is induced by reactive oxygen species, and casepase-2 is said to play a crucial role in the control of apoptosis [61, 62]. It is also said that activation of caspase-2 is essential to T-2 toxin-induced apoptosis and that apoptotic signals are mainly transmitted via caspase-8 and caspase-3 rather than mitochondrial pathway [63]. On the other hand, apoptosis induction in the fetal brain by T-2 toxin seems to be independent of the p53-related pathway which is the most important pathway in DNA-damaging agent-induced apoptosis of neuronal progenitor cells in the developing brain [6468].

4. Relationship between maternal and fetal toxicities

Sehata et al. [41] reported that prenatal exposure to T-2 toxin (2 mg/kg) induces apoptosis in maternal tissues, placenta and fetal tissues. For example, apoptotic cells bearing pyknotic or karyorrhectic nucleus and condensed eoshinophilic cytoplasm are observed in maternal liver (hepatocytes), placenta (cytotrophoblasts) and fetal liver (hepatocytes and hematopoietic cells) (Figure 1). Based on the results of microarray analysis at 23 hr after T-2 toxin (2 mg/kg) exposure on day 13 of gestation, they suggested that T-2 toxin induces oxidative stress in these tissues following the changes in metabolism–related gene expression and that these changes may alter the intracellular environments resulting in the induction of apoptosis [69]. They further investigated the mechanisms of apoptosis in the maternal liver, placenta and fetal liver at earlier time points [70].
The apoptotic index peaked at 6 hr and at 12 hr in the maternal liver and placenta, respectively, and it decreased thereafter. In the fetal liver, it reached a plateau at 12 hr. Microarray analysis done on these tissues at 3, 6 or 12 (peak time point of apoptosis), and 24 hr showed changes in the expression of many genes. Increased expression of oxidative stress- and apoptosis-related genes was commonly detected in these three tissues at the peak time point of apoptosis, and decreased expression of lipid metabolism- and drug-metabolizing enzyme-related genes was also commonly detected in these three tissues (Figure 2). Therefore, the mechanism of T-2 toxin-induced toxicity in pregnant rats is considered to be due to oxidative stress followed by the activation of MAPK pathway, finally inducing apoptosis, as reported in the fetal brain [60].
Oxidative stress is certainly involved in the toxicities of trichothecene mycotoxins including T-2 toxin [71], MAPKs may play integral roles in the diverse toxic manifestations of trichotecenes [72], and ribosome binding or protein synthesis inhibition may play roles in MAPK activation and apoptosis induction by trichothecenes [6, 72]. Oxidative stress causes lipid peroxidation and induces mitochondrial dysfunction which causes fatty acid β-oxidation and induces fatty liver [73]. In addition, T-2 toxin enhances lipid peroxidation [10, 74]. Therefore, the disturbance of lipid metabolism caused by oxidative stress may occur in the maternal liver, placenta and fetal liver by T-2 toxin [70].
Increased expression of Bax-α as well as p53 was detected in maternal and fetal livers [70]. Bax, one of the p53’s target genes, is a member of the bcl-2 family and induces apoptosis, and apoptosis induction in HL60 cells by T-2 toxin involves activation of caspase-3 and –9 through the release of cytochrome c from mitochondria in the cytosol [76], suggesting the involvement of p53-related mitochondrial pathway in the T-2 toxin-induced apoptosis at least in the maternal and fetal livers. On the other hand, differing from the above-mentioned case of T-2 toxin-induced apoptosis in the fetal brain [60], increased expression of casepase-2 gene was not detected in the maternal liver, placenta and fetal liver. In addition, unlike DNA-damaging agent-induced placental apoptosis [75], p53 was not involved in T-2 toxin-induced placental apoptosis [70].
The number of metabolism-related genes in the placenta is smaller than those in the maternal liver and fetal liver, suggesting that the placenta might play a less role in T-2 toxin metabolism. In addition, the differences in the expression of cytochrome P-450 genes between the maternal liver and fetal liver might reflect the difference in the basic expression of cytochrome P-450 genes between the maternal liver and fetal liver.

5. Conclusions

T-2 toxin readily passes the placenta and directly affects the fetus, resulting in the induction of apoptotic cell death mainly in the fetal lymphoid, central nervous and skeletal systems and liver. In dams, T-2 toxin induces apoptotic cell death in the placenta in addition to the tissues which are reported to be sensitive to T-2 toxin in adult mice and rats. The mechanisms of T-2 toxin-induced maternal and fetal toxicities are due to oxidative stress, followed by activation of the MAPK pathway, finally inducing apoptotic cell death (Figure 3). However, there are some differences in additive pathways involved in T-2 toxin-induced apoptosis among tissues affected (Figure 3).

Acknowledgments

The authors would like to thank Dr. Pete Aughton, D.A.B.T., ITR Laboratories Canada Inc., for proof reading.

References

  1. Desjardins, AE; Hohn, TM; McCormic, SP. Trichothecene Biosynthesis in Fusarium Species: Chemistry, Genetics, and Significance. Microbiol. Rev 1993, 57, 595–604. [Google Scholar]
  2. Nelson, PE; Dignani, MC; Anaissie, EJ. Taxonomy, Biology, and Clinical Aspects of Fusarium Species. Clin. Microbiol. Rev 1994, 7, 479–504. [Google Scholar]
  3. Joffe, AZ. Foodborne Diseases: Alimentary Toxic Aleukia. In Handbook of Foodborne Diseases of Biological Origin; Rochcigle, M, Ed.; CRC Press: Boca Raton, FL, 1983; pp. 353–495. [Google Scholar]
  4. Saito, M; Ohtsubo, K. Trichothecene Toxins of Fusarium Species. In Mycotoxins; Purchase, IFH, Ed.; Elsevier Scientific Publication: New York, 1977; pp. 264–280. [Google Scholar]
  5. Ueno, Y; Ishii, K; Saki, K; Kanadera, K; Tsunoda, S; Tanoka, H; Enomoto, M. Toxicological Approaches to the Metabolites of Fusaria. IV. Microbial Survey on “Bean-Hulls Poisoning of Horses” with the Isolation of Toxic Trichothecenes, Neosonaniol and T-2 Toxin of Fusarium solani M-1-1. Jpn. J. Exp. Med 1972, 42, 187–203. [Google Scholar]
  6. Shifrin, VI; Anderson, P. Trichothecene Mycotoxins Trigger a Ribotoxic Stress Response that Activates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase and Induces Apoptosis. J. Biol. Chem 1999, 274, 13985–13992. [Google Scholar]
  7. Bennet, JW; Klich, M. Mycotoxins. Clin. Microviol. Rev 2003, 16, 497–516. [Google Scholar]
  8. Eriksen, GS; Petterson, H. Toxicological Evaluation of Trichothecenes in Animal Feed. Anim. Feed Sci. Technol 2004, 114, 205–239. [Google Scholar]
  9. Thompson, WL; Wannemacher, RW, Jr. In Vivo Effects of T-2 Mycotoxin on Synthesis of Protein and DNA in Rat Tissues. Toxicol. Appl. Pharmacol 1990, 105, 483–491. [Google Scholar]
  10. Chang, IM; Mar, WC. Effect of T-2 Toxin on Lipid Peroxidation in Rats: Elevation of Conjugated Diene Formation. Toxicol. Lett 1988, 40, 275–280. [Google Scholar]
  11. Eriksen, GS; Petterson, H; Lund, H. Comparative Cytotoxicity of Deoxynivalenol, Nivalenol, Theiracetylated Derivatives and De-Epoxy Metabolites. Food Chem. Toxicol 2004, 42, 619–624. [Google Scholar]
  12. Donal, V; Jezkova, A; Jun, D; Kuca, K. Metabolic Pathways of T-2 Toxin. Curr. Drug Metab 2008, 9, 77–82. [Google Scholar]
  13. Stanford, GK; Hood, RD; Haynes, AW. Effects of Prenatal Administration of T-2 Toxin to Mice. Res. Commu. Chem. Pathol. Pharmacol 1975, 10, 743–746. [Google Scholar]
  14. Williams, PP. Effects of T-2 Mycotoxin on Gastrointestinal Tissues: A View of in Vivo and in Vitro Models. Arch. Environ. Contam. Toxicol 1989, 18, 374–387. [Google Scholar]
  15. IARC. Toxins derived from Fusarium sporotrichioides: T-2 Toxin. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, 1993; pp. 467–488. [Google Scholar]
  16. Sharma, RP. Immunotoxicity of Mycotoxins. J. Dairy Sci 1993, 76, 892–897. [Google Scholar]
  17. Magnuson, BA; Schiefer, HB; Hancock, DS; Bhatti, AR. Cardiovascular Effects of Mycotoxin T-2 after Topical Application in Rats. Can. J. Physiol. Pharmacol 1987, 65, 799–802. [Google Scholar]
  18. Lutsky, I; Mor, N. Experimental Alimentary Toxic Aleukia in Cats. Lab. Anim. Sci 1981, 31, 43–47. [Google Scholar]
  19. Quiroga, MA; Itagaki, S; Doi, K. Early Ultrastructural Changes of Thymocytes in T-2 Toxicated Mice. J. Toxicol. Pathol 1993, 6, 109–112. [Google Scholar]
  20. Shinozuka, J; Li, G; Kiatipattanasakul, W; Uetsuka, K; Nakayama, H; Doi, K. T-2 Toxin-induced Apoptosis in Lymphoid Organs of Mice. Exp. Toxicol. Pathol 1997, 49, 387–392. [Google Scholar]
  21. Li, G; Shinozuka, J; Uetsuka, K; Nakayama, H; Doi, K. T-2 Toxin-induced Apoptosis in Peyer’s Patches of Mice. J. Toxicol. Pathol 1997, 10, 59–61. [Google Scholar]
  22. Shinozuka, J; Suzuki, M; Noguchi, N; Sugimoto, T; Uetsuka, K; Nakayama, H; Doi, K. T-2 Toxin-induced Apoptosis in Hematopoietic Tissues of Mice. Toxicol. Pathol 1998, 26, 674–681. [Google Scholar]
  23. Li, G; Shinozuka, J; Uetsuka, K; Nakayama, H; Doi, K. T- 2 Toxin- induced Apoptosis in Intestinal Crypt Epithelial Cells of Mice. Exp. Toxico. Pathol 1997, 49, 447–450. [Google Scholar]
  24. Albarenque, SM; Shinozuka, J; Iwamoto, S; Nakayama, H; Doi, K. T-2 Toxin-induced Acute Skin Lesions in Wistar-Derived Hypotrichotic WBN/ILA-Ht Rats. Histol. Histopathol 1999, 14, 337–342. [Google Scholar]
  25. Shinozuka, J; Miwa, S; Fujimura, H; Toriumi, W; Doi, K. Hepatotoxicity of T-2 Toxin, Trichothecene Mycotoxin. In New Strategies for Mycotoxin research in Asia (Proceedings of ISMYCO Bangkok ’06); Kumagai, S, Ed.; Japanese Association of Mycotoxicology: Tokyo, 2007; pp. 62–66. [Google Scholar]
  26. Albarenque, SM; Shinozuka, J; Suzuki, K; Nakayama, H; Doi, K. Kinetics and Distribution of Transforming Growth Factor (TGF)-β1 mRNA in the Dorsal Skin of Hypotrichotic WBN/ILA-Ht Rats Following Topical Application of T-2 Toxin. Exp. Toxicol. Pathol 2000, 52, 297–301. [Google Scholar]
  27. Albarenque, SM; Suzuki, K; Nakayama, H; Doi, K. Kinetics of Cytokines mRNAs Expression in the Dorsal Skin of WBN/ILA-Ht Rats Following Topical Application of T-2 Toxin. Exp. Toxicol. Pathol 2001, 53, 271–274. [Google Scholar]
  28. Albarenque, SM; Suzuki, K; Shinozuka, J; Nakayama, H; Doi, K. Kinetics of Apoptosis-related Genes mRNAs Expression in the Dorsal Skin of HypotrichoticWBN/ILA-Ht Rats after Topical Application of T-2 Toxin. Exp. Toxicol. Pathol 2001, 52, 553–556. [Google Scholar]
  29. Albarenque, SM; Doi, K. T-2 Toxin-induced Apoptosis in Rat Keratinocyte Primary Cultures. Exp. Mol. Pathol 2005, 78, 144–149. [Google Scholar]
  30. Lafarge-Frayssinet, C; Chakor, K; Lafont, P; Frayssinet, C. Transplacental Transfer of T2 Toxin: Pathological Effect. J. Environ. Pathol. Toxicol. Oncol 1990, 10, 64–68. [Google Scholar]
  31. Schoental, R. Chronic, Including Teratogenic and Carcinogenic Effects of Trichothecenes: A Short Review. Vet. Res. Comm 1983, 7, 165–170. [Google Scholar]
  32. Khera, KS. Maternal Toxicity-A Possible Factor in Fetal Malformations in Mice. Teratology 1984, 29, 411–416. [Google Scholar]
  33. Schiefer, HB. Lethal Hemorrhages in Pregnant Mice Following One Oral Dose of T-2 Toxin. Arch. Belg. 1984, Suppl., 252–253. [Google Scholar]
  34. Hood, RD; Kuczuk, MH; Szczech, GM. Effects in Mice of Simultaneous Prenatal Exposure to Ochratoxin A and T-2 Toxin. Teratology 1978, 17, 25–30. [Google Scholar]
  35. Blakley, BR; Hancock, DS; Rousseaux, CG. Embryotoxic Effects of Prenatal T-2 Toxin Exposure in Mice. Can. J. Vet. Res 1987, 51, 399–403. [Google Scholar]
  36. Rousseaux, CG; Schiefer, HB. Maternal Toxicity, Embryolethality and Abnormal Fetal Development in CD-1 Mice Following One Oral Dose of T-2 Toxin. J. Appl. Toxicol 1987, 7, 281–288. [Google Scholar]
  37. Holladay, SD; Blaylock, BL; Comment, CE; Heindel, JJ; Luster, MI. Fetal Thymic Atrophy after Exposure to T-2 Toxin: Selectivity for Lymphoid Progenitor Cells. Toxicol. Appl. Pharmacol 1993, 121, 8–14. [Google Scholar]
  38. Holladay, SD; Smith, BJ; Luster, MIB. Lymphocyte Precursor Cells Represent Sensitive Targets of T2 Mycotoxin Exposure. Toxicol. Appl. Pharmacol 1995, 131, 309–315. [Google Scholar]
  39. Ishigami, N; Shinozuka, J; Katayama, K; Uetsuka, K; Nakayama, H; Doi, K. Apoptosis in the Developing Mouse Embryos from T-2 Toxin-inoculted Dams. Histol. Histopathol 1999, 14, 729–733. [Google Scholar]
  40. Ishigami, N; Shinozuka, J; Katayama, K; Nakayama, H; Doi, K. Apoptosis in Mouse Fetuses from Dams Exposed to T-2 Toxin at Different Days of Gestation. Exp. Toxicol. Pathol 2001, 52, 493–501. [Google Scholar]
  41. Sehata, S; Teranishi, M; Atsumi, F; Uetsuka, K; Nakayama, H; Doi, K. T-2 Toxin-induced Morphological Changes in Pregnant Rats. J. Toxicol. Pathol 2003, 16, 59–65. [Google Scholar]
  42. Sehata, S; Teranishi, M; Yamoto, T; Matsunuma, N; Doi, K. T-2 Toxin-Induced Toxicity in Pregnant Rats-Histopathology and Gene Expression Profiles-. In New Horizon of Mycotoxicology for Assuring Food Safety (Proceedings of ISMYCO Kagawa ’03); Yoshizawa, T, Ed.; Japanese Association of Mycotoxicology: Tokyo, 2004; pp. 33–39. [Google Scholar]
  43. Shinozuka, J; Tsutsui, S; Ishigami, N; Ueno-yamanouchi, A; Nakayama, H; Doi, K. Development of Apoptosis and Changes in Apoptosis-related Genes Expression in the Mouse Thymus Following T-2 Toxin-Inoculation. J. Toxicol. Pathol 1999, 12, 77–81. [Google Scholar]
  44. Shinozuka, J; Suzuki, H; Tsutsui, S; Nakayama, H; Doi, K. T-2 Toxin-induced Apoptosis and C-Fos mRNA Expression in ConA-Stimulated Mouse Thymocyte Primary Culture. J. Toxicol. Pathol 2001, 14, 247–251. [Google Scholar]
  45. Holme, JA; Morrison, E; Samuelsen, JT; Wiger, R; Lag, M; Schwarze, PE; Bernhoft, A; Refsnes, M. Mechanisms Involved in the Induction of Apoptosis by T-2 and HT-2 Toxins in HL-60 Human Promyelocytic Leukemia Cells. Cell. Biol. Toxicol 2003, 19, 53–68. [Google Scholar]
  46. Murshedul, AM; Nagase, M; Yoshizawa, T; Sakato, N. Thymocyte Apoptosis by T-2 Toxin in Vivo in Mice is Independent of Fas/Fas Ligand System. Biosci. Biotechnol. Biochem 2000, 64, 210–213. [Google Scholar]
  47. Rousseaux, CG; Nicholson, S; Schiefer, HB. Fatal Placental Hemorrhage in Pregnant CD-1 Mice Following One Oral Dose of T-2 Toxin. Can. J. Comp. Med 1985, 4, 95–98. [Google Scholar]
  48. Haynes, AW. Mycotoxin Teratogenicity. In Toxins: Animal, Plant and Microbial; Rosenberg, P, Ed.; Pergamon Press: New York, 1978; pp. 739–759. [Google Scholar]
  49. Gentry, PA; Cooper, ML. Effect of Fusarium T-2 Toxin on Hemorrhagical and Biochemical Parameters in the Rabbit. Can. J. Comp. Med 1981, 45, 400–405. [Google Scholar]
  50. Yarom, R; More, R; Eldor, A; Yagen, B. The Effect of T-2 Toxin on Human Platelets. Toxicol. Appl. Pharmacol 1984, 73, 210–217. [Google Scholar]
  51. Rousseaux, CG; Schiefer, HB; Hancock, DS. Reproductive and Teratological Effects of Continuous Low Level Dietary T-2 Toxin in Female CD-1 Mice for Two Generations. J. Appl. Toxicol 1986, 6, 179–184. [Google Scholar]
  52. Husmann, LA; Shimonkevitz, RP; Crispe, IN; Bevan, MJ. Thymocyte Subpopulation during Early Fetal Development in the BALB/c Mouse. J. Immunol 1988, 141, 736–740. [Google Scholar]
  53. Penit, C; Vaddeur, F. Cell Proliferation and Differentiation in Fetal and Early Postnatal Mouse Thymus. J. Immun 1989, 142, 3369–3377. [Google Scholar]
  54. Nagata, T; Suzuki, H; Ishigama, N; Shinozuka, J; Uetsuka, K; Nakayama, H; Doi, K. Development of Apoptosis and Changes in Lymphocyte Subsets in Thymus, Mesenteric Lymph Nodes and Peyer’s Patches of Mice Orally Inoculated with T-2 Toxin. Exp. Toxicol. Pathol 2001, 53, 309–315. [Google Scholar]
  55. Roberts, DW; Chapman, JR. Concepts Essential to the Assessment of Toxicity to the Developing Immune System. In Developmental Toxicology; Kimmel, CA, Buelke-Sam, J, Eds.; Raven Press: New York, 1981; pp. 167–189. [Google Scholar]
  56. Quiroga, MA; Risso, MA; Perfumo, CJ; Idiart, JR; Ohtsuka, R; Doi, K. Sequence of and Regional Difference in Apoptotic Index in the Mouse Gastrointestinal Mucous Epithelia after T-2 Toxin Inoculation. J. Toxicol. Pathol 2000, 13, 193–196. [Google Scholar]
  57. Fu, YT; Lin, WG; BaoCheng, Z; Quan, G. The Effect of T-2 Toxin on IL-1β and IL-6 Secretion in Human Fetal Chondrocytes. Int. Orthop 2001, 25, 199–201. [Google Scholar]
  58. Chen, J; Chu, Y; Cao, J; Yang, Z; Guo, X; Wang, Z. T-2 Toxin Induces Apoptosis, and Selenium Partly Blocks T-2 toxin-Induced Apoptosis in Chndrocytes through Modulation of the Bax/Bcl-2 Ratio. Food Chem. Toxicol 2006, 44, 567–573. [Google Scholar]
  59. Kniesel, U; Risua, W; Wolburg, H. Development of Blood-Brain Barrier Tight Junctions in the Rat Cortex. Brain Res. Dev. Brain Res 1996, 23, 229–240. [Google Scholar]
  60. Sehata, S; Kiyosawa, N; Makino, T; Atsumi, F; Ito, K; Yamoto, T; Teranishi, M; Baba, Y; Uetsuka, K; Nakayama, H; Doi, K. Morphological and Microarray Analysis of T-2 Toxin-induced Rat Fetal Brain Lesion. Food Chem. Toxicol 2004, 4, 1727–1736. [Google Scholar]
  61. Annunziato, L; Amoroso, S; Pannaccione, A; Cataldi, M; Pignataro, G; D’Alessio, A; Sirabella, R; Secondo, A; Sibaud, L; Di Renzo, GF. Apoptosis Induced in Neuronal Cells by Oxidative Stress: Role Played by Caspases and Intracellular Calcium Ions. Toxicol. Lett 2003, 139, 125–133. [Google Scholar]
  62. Troy, CM; Shelanski, ML. Caspase–2 Redux. Cell. Death Different 2003, 10, 101–107. [Google Scholar]
  63. Huang, P; Akagawa, K; Yokoyama, Y; Nohara, K; Kano, K; Morimoto, K. T-2 Toxin Initially Activates Caspase–2 and Induces Apoptosis in U937 Cells. Toxicol. Lett 2007, 170, 1–10. [Google Scholar]
  64. Katayama, K; Ueno, M; Yamauchi, H; Nagata, T; Nakayama, H; Doi, K. Ethylnitrosourea Induces Neuronal Progenitor Cell Apoptosis after S-Phase Accumulation in a p53-dependent Manner. Neurobiol. Dis 2005, 18, 218–225. [Google Scholar]
  65. Nam, C; Yamauchi, H; Nakayama, H; Doi, K. Etoposide Induces Apoptosis and Cell Cycle Arrest of Neuroepithelial Cells in a P53-dependent Manner. Neurotoxicol. Teratol 2006, 28, 664–672. [Google Scholar]
  66. Ueno, M; Katayama, K; Yamauchi, H; Nakayama, H; Doi, K. Cell Cycle and Cell Death Regulation of Neural Progenitor Cells in the 5-Azacytidine (5AzC)-treated Developing Fetal Brain. Exp. Neurol 2006, 198, 154–166. [Google Scholar]
  67. Woo, GH; Bak, EJ; Nakayama, H; Doi, K. Molecular Mechanisms of Hydroxyurea (HU)-induced Apoptosis in the Mouse Fetal Brain. Neurotoxicol. Teratol 2006, 28, 125–134. [Google Scholar]
  68. Yamauchi, H; Katayama, K; Ueno, M; Uetsuka, K; Nakayama, H; Doi, K. Involvement of P53 in 1-β-D-Arabinofuranosylcytosine-induced Rat Fetal Brain Lesions. Neurotoxicol. Teratol 2004, 26, 57–586. [Google Scholar]
  69. Sehata, S; Kiyosawa, N; Sakuma, K; Ito, K; Yamoto, T; Teranishi, M; Uetsuka, K; Nakayama, H; Doi, K. Gene Expression Profiles in Pregnant Rats Treated with T-2 Toxin. Exp. Toxicol. Pathol 2004, 55, 357–366. [Google Scholar]
  70. Sehata, S; Kiyosawa, N; Atsumi, F; Ito, K; Yamoto, T; Teranishi, M; Uetsuka, K; Nakayama, H; Doi, K. Microarray Analysis of T-2 Toxin-induced Liver, Placenta and Fetal Liver Lesions in Pregnant Rats. Exp. Toxicol. Pathol 2005, 57, 15–28. [Google Scholar]
  71. El Golli, E; Hassen, W; Bouslimi, A; Bouaziz, C; Ladjimi, MM; Bacha, H. Induction of Hsp 70 in Vero Cells in Response to Mycotoxins Cytoprotection by Sub-Lethal Heat Shock and by Vitamin E. Toxicol. Lett 2006, 166, 122–130. [Google Scholar]
  72. Yang, G; Jarvis, BB; Chung, J; Pestka, JJ. Apoptosis Induction by the Satratoxins and Other Trichothecene Mycotoxins: Relationship to ERK, P38 MAPK, and SAPK/JNK Activation. Toxicol. Appl. Pharmacol 2000, 15. [Google Scholar]
  73. Jaeschke, H; Gores, GJ; Cederbaum, AI; Hinson, JA; Pessayre, D; Lemasters, JJ. Mechanisms of Hepatotoxicity. Toxicol. Sci 2002, 65, 166–176. [Google Scholar]
  74. Vila, B; Jaradat, ZW; Marquardt, RR; Frohlich, AA. Effect of T-2 Toxin on in Vivo Lipid Peroxidation and Vitamin E Status in Mice. Food Chem. Toxicol 2002, 40, 479–486. [Google Scholar]
  75. Nagase, M; Alam, MM; Tsushima, A; Yoshizawa, T; Sakato, N. Apoptosis Induction by T-2 Toxin: Activation of Caspase–9, Caspase– 3, and DFF- 40/CAD through Cytosolic Release of Cytochrome c in HL- 60 Cells. Biosci. Biotechnol. Biochem 2001, 65, 1741–1947. [Google Scholar]
  76. Yamauchi, H; Katayama, K; Ueno, M; He, XJ; Mikami, T; Uetsuka, K; Doi, K; Nakayama, H. Essential Role of p53 in Trophoblastic Apoptosis Induced in the Developing Rodent Placenta by Treatment with a DNA-Damaging Agent. Apoptosis 2007, 12, 1943–1754. [Google Scholar]
Figure 1. Histopathology of maternal liver (a), placenta (b) and fetal liver (c) obtained from pregnant rats at 6 hr after treatment with T-2 toxin (2 mg/kg) on day 13 of gestation. An arrowhead indicates apoptotic hepatocyte (a and c) and cytotrophoblast (b), and an arrow indicates apoptotic hematopoietic cell (c). Apoptotic cells show pyknotic or karyorrhectic nucleus and condensed eosinophilic cytoplasm. Hematoxylin and eosin stain, × 100 (original magnification).
Figure 1. Histopathology of maternal liver (a), placenta (b) and fetal liver (c) obtained from pregnant rats at 6 hr after treatment with T-2 toxin (2 mg/kg) on day 13 of gestation. An arrowhead indicates apoptotic hepatocyte (a and c) and cytotrophoblast (b), and an arrow indicates apoptotic hematopoietic cell (c). Apoptotic cells show pyknotic or karyorrhectic nucleus and condensed eosinophilic cytoplasm. Hematoxylin and eosin stain, × 100 (original magnification).
Ijms 09 02146f1
Figure 2. Summary of DNA microarray analysis done on maternal liver, placenta and fetal liver obtained from pregnant rats treated with T-2 toxin on day 13 of gestation.
Figure 2. Summary of DNA microarray analysis done on maternal liver, placenta and fetal liver obtained from pregnant rats treated with T-2 toxin on day 13 of gestation.
Ijms 09 02146f2
Figure 3. Hypothesis of mechanisms involved in T-2 toxin-induced apoptosis in maternal and fetal tissues. ER: endoplasmic reticulum; Mt: mitochondrion. 1 Main pathway, 2 Additive pathway in hematopoietic and lymphoid tissues, 3Additive pathway in maternal and fetal liver, 4Additive pathway in fetal brain.
Figure 3. Hypothesis of mechanisms involved in T-2 toxin-induced apoptosis in maternal and fetal tissues. ER: endoplasmic reticulum; Mt: mitochondrion. 1 Main pathway, 2 Additive pathway in hematopoietic and lymphoid tissues, 3Additive pathway in maternal and fetal liver, 4Additive pathway in fetal brain.
Ijms 09 02146f3

Share and Cite

MDPI and ACS Style

Doi, K.; Ishigami, N.; Sehata, S. T-2 Toxin-induced Toxicity in Pregnant Mice and Rats. Int. J. Mol. Sci. 2008, 9, 2146-2158. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms9112146

AMA Style

Doi K, Ishigami N, Sehata S. T-2 Toxin-induced Toxicity in Pregnant Mice and Rats. International Journal of Molecular Sciences. 2008; 9(11):2146-2158. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms9112146

Chicago/Turabian Style

Doi, Kunio, Noriaki Ishigami, and Shinya Sehata. 2008. "T-2 Toxin-induced Toxicity in Pregnant Mice and Rats" International Journal of Molecular Sciences 9, no. 11: 2146-2158. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms9112146

Article Metrics

Back to TopTop